✦ LIBER ✦

18LBA A GCIG randomized phase III study of carboplatin (C) & pegylated liposomal doxorubicin (PLD) (C-D) vs carboplatin (C) & paclitaxel (P) (C-P): CALYPSO results in partially platinum-sensitive ovarian cancer (OC) patients

✍ Scribed by P. Vasey; R. Largillier; M. Gropp; V. Gebski; R. Sandvei; L. Elit; L. Angleitner-Boubezinek; N. Reed; S. Pignata; A.M. Ferrero

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Final overall survival results of phase

✍ Wagner, U; Marth, C; Largillier, R; Kaern, J; Brown, C; Heywood, M; Bonaventura, 📂 Article 📅 2012 🏛 Nature Publishing Group 🌐 English ⚖ 242 KB

Carboplatin and pegylated liposomal doxo

✍ Gladieff, L.; Ferrero, A.; De Rauglaudre, G.; Brown, C.; Vasey, P.; Reinthaller, 📂 Article 📅 2012 🏛 Oxford University Press 🌐 English ⚖ 124 KB

A randomized phase II study of carboplat

✍ Dimitrios Bafaloukos; Helena Linardou; Gerasimos Aravantinos; Christos Papadimit 📂 Article 📅 2010 🏛 BioMed Central 🌐 English ⚖ 332 KB

5003 ORAL A randomised phase II study of

✍ Linardou, H.; Bafaloukos, D.; Bamias, A.; Xanthakis, I.; Kalofonos, H.P.; Aravan 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 59 KB

Randomized trial of pegylated liposomal

✍ David S. Alberts; P.Y. Liu; Sharon P. Wilczynski; Mary C. Clouser; Ana Maria Lop 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 163 KB

Fixed-dose rate gemcitabine plus carbopl

✍ Ronald D. Alvarez; Robert Mannel; Agustin A. García; Holly H. Gallion; Joseph Lu 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 246 KB